â– PHYSIOLOGICAL CORE: Insulin is a peptide hormone secreted by pancreatic beta cells in response to elevated blood glucose and amino acids, coordinating postprandial energy storage.
â– RETRIEVAL TRANSPORTERS:
1. Receptor Activation: Insulin binds to its transmembrane tyrosine kinase receptor, triggering autophosphorylation.
2. Signaling Cascades: Activates its substrate proteins (IRS-1/2), which stimulate the PI3K/Akt signaling pathway.
3. GLUT4 Translocation: Stimulates the translocation and fusion of vesicles containing insulin-sensitive GLUT4 glucose transporters to the cell membrane.
4. Target Organs: GLUT4 is expressed in skeletal muscle and adipose tissue, driving glucose uptake.
5. Insulin-Independent Tissues: Brain (GLUT1/3), RBCs (GLUT1), liver, and pancreatic beta cells (GLUT2) absorb glucose independently of insulin.
â– RADIOGRAPHIC DIAGNOSTIC CRITERIA:
Imaging modalities (such as high-resolution CT, contrast-enhanced MRI, and point-of-care ultrasound) show characteristic density shifts, enhancement patterns, or structural deviations.
â– EPIDEMIOLOGICAL PROFILE & DENSITY CORRELATIONS:
Global burden patterns reveal notable associations with lifestyle habits, regional environmental factors, and inherited traits.
[HY-BOARD-1357]
🌟 Dynamic Clinical Key:
In Type 2 Diabetes, target tissues exhibit insulin resistance: the downstream signaling cascade is impaired, preventing appropriate GLUT4 translocation. This leads to hyperglycemia. Metformin helps manage this by activating AMPK to stimulate glucose uptake via insulin-independent pathways. Always correlate imaging signs with clinical presentation to avoid unnecessary surgical explorations of benign incidentalomas. Focus screening efforts on high-risk geographic regions to maximize clinical yield.